¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29
±³À°ÀÏÀÚ : 2023-04-29
±³À°Àå¼Ò : º¤½ºÄÚ Á¦2Àü½ÃÀå 1Ãþ 121È£

±³À°ÁÖÁ¦ : 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­ÁÂ

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ

´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 051-000-0000

À̸ÞÀÏ : sericonf@gmail.com

±³À°Á¾·ù : ³»°ú, ÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇ·áÁ¤Ã¥, ±âŸ

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:00~09:15 Optimal antiplatelet strategy in patients both at high ischemic and bleeding risks ¾È¼­Èñ(¿ï»ê´ë)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:15~09:30 Optimal revascularization strategy for ICMP ±è¼öÈ«(ºÎ»ê º¸Èƺ´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:30~09:45 Early versus delayed intervention for NSTEMI patients ±èÇÑ°á(°æ»ó±¹¸³´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 09:45~10:00 Physiology guided vs imaging guided PCI ¿ÀÁØÇõ(ºÎ»ê´ëº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:00~10:20 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:20~10:30 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:30~10:45 Practical tips for diagnosing HFpEF, featuring concept of congestion ÀåÁ¤À±(â¿ø°æ»ó´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 10:45~11:00 How to implement 4 pillar therapy in HFrEF À̼ö¿ë(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:00~11:15 How to detect & treat ATTR amyloidosis in daily practice ¼­Á¤¼÷(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:15~11:30 Approach to asymptomatic coronary artery calcium in chest CT ±èºÀÁØ(°í½Å´ëº¹À½º´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:30~11:50 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 11:50~12:00 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 12:00~12:30 Earlier & Lower is Better! - Clinical Benefits of Evolocumab in ACS Á¶¿ë¶ô(µ¿¾Æ´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 12:30~13:00 Familial Hypercholesterolemia: It¡¯s Possible! How to Screen and Treat? ¹Ú°æ¹Î(¿ï»ê´ëº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:00~13:15 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:15~13:30 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:30~13:45 SGLT2 inhibitor and AF Ȳ±â¿ø(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 13:45~14:00 The use of non‐vitamin K oral anticoagulants in patients with AF and dialysis °ûÇýºó(â¿ø»ï¼ºº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:00~14:15 Left Bundle Branch Pacing Versus Biventricular Pacing In heart failure ¹Ú¿µ¾Æ(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:15~14:30 New Technology in AF Ablation: Pulsed Field Ablation ÀÓ¼ºÀÏ(°í½Å´ëº¹À½º´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:30~14:50 Discussion ( )

ÈÞ½Ä 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 14:50~15:00 Break ( )

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 15:00~15:45 Patient indication & assessment of TEER during procedure ¹Ú¼ºÁö(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 15:45~16:30 A to Z of TEER procedures ÇÑÁÖ¿ë(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 04¿ù 29ÀÏ Á¦2Àü½ÃÀå 1Ãþ 121È£ 16:30~16:50 Discussion ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2023³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Ãá°è¿¬¼ö°­Á : 2023-04-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (3ÀÏÂ÷) : 2023-04-29
´ÙÀ½±Û ¿µ³²»ý½Ä³»ºÐºñÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2023-04-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20530 ¼­¿ï ¿¡ÀÌÄ¡Ç÷¯½º¾çÁöº´¿ø Á¦2024-1ȸ ¿¬¼ö°­Á : 2024-05-23 0 20 2024-04-29
20529 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ : 2024-05-21 0 6 2024-04-29
20528 ¼­¿ï Á¾·Î±¸ÀÇ»çȸ ȸ¿ø¿¬¼ö±³À°(¾ß°£´¢, ´ç´¢Ä¡·á, ¹ß±âºÎÀü) : 2024-05-21 0 38 2024-04-29
20527 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦2Â÷ ¿¬¼ö±³À° : 2024-05-20 0 7 2024-04-29
20526 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ADHD ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-05-19 0 16 2024-04-29
20525 ¼­¿ï ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ 2024 KSCTVA Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-19 0 18 2024-04-29
20524 ´ë±¸ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 16 2024-04-29
20523 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 19 2024-04-29
20522 ¼­¿ï 2024³â ´ëÇѱÙÀüµµÀü±âÁø´ÜÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 26 2024-04-29
20521 ¼­¿ï ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-05-18 0 22 2024-04-29
20520 ¿ï»ê ¿ï»ê±¤¿ª½ÃÀÇ»çȸ Ç÷°üÀ» Á¶½ÉÇÏÀÚ : 2024-05-18 0 20 2024-04-29
20519 ¼­¿ï ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ 2024 KSCTVA Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-18 0 11 2024-04-29
20518 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø ¾È°ú ½ÉÆ÷Áö¾ö : 2024-05-18 0 35 2024-04-29
20517 ¼­¿ï ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-¼Â°³¯ : 2024-05-18 0 18 2024-04-29
20516 ¼­¿ï Á¦7ȸ °­ºÏ±¸ÀÇ»çȸ Çмú´ëȸ : 2024-05-18 0 23 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷